文献速递泌尿生殖技术与安全PETCT

68Ga-PSMA PET/CT对疑似前列腺癌患者初始检测的诊断准确性:系统评价与Meta分析

Diagnostic Accuracy of 68Ga-PSMA PET/CT for Initial Detection in Patients With Suspected Prostate Cancer: A Systematic Review and Meta-Analysis.
PubMed 文献 · AJR Am J Roentgenol · 2021-01-21

该系统评价与Meta分析纳入7项研究共389例临床或生化检查疑似前列腺癌患者,以组织病理学为参考标准,评估68Ga-PSMA PET/CT初始诊断前列腺癌的准确性。汇总敏感度0.97(95%CI 0.90-0.99)、特异度0.66(95%CI 0.52-0.78),SROC曲线下面积0.91(95%CI 0.88-0.93)。作者认为该检查具有高诊断准确性,可能作为疑似患者的排除性检查。

要点

  • 68Ga-PSMA PET/CT初始诊断前列腺癌汇总敏感度0.97,特异度0.66,SROC曲线下面积0.91。
  • 汇总阳性似然比2.86(95%CI 1.95-4.20),阴性似然比0.05(95%CI 0.01-0.15)。
  • 作者认为该检查对临床或生化疑似前列腺癌患者具有高诊断准确性,可能用作排除性检查。

核心结论

  • 68Ga-PSMA PET/CT对临床或生化检查疑似前列腺癌患者的初始诊断具有极好的敏感度和阴性似然比。
  • 该检查对疑似前列腺癌的初始检测具有高诊断准确性,可能作为这些患者的排除性检查。

研究设计与样本

  • 系统评价与Meta分析,遵循PRISMA指南,检索PubMed、Scopus和Embase数据库,纳入截至2020年4月30日发表的文献。
  • 共纳入7项研究、389例临床或生化检查疑似前列腺癌的患者。
  • 以组织病理学结果为参考标准,提取真阳性、假阳性、真阴性和假阴性数。
  • 采用双变量随机效应Meta分析生成汇总敏感度、特异度、阳性似然比、阴性似然比和SROC曲线。

诊断标准与关键数值

  • 68Ga-PSMA PET/CT初始诊断前列腺癌的汇总敏感度为0.97(95%CI 0.90-0.99)。
  • 汇总特异度为0.66(95%CI 0.52-0.78)。
  • 汇总阳性似然比为2.86(95%CI 1.95-4.20),阴性似然比为0.05(95%CI 0.01-0.15)。
  • SROC曲线下面积为0.91(95%CI 0.88-0.93)。

临床应用与阅片要点

  • 对于临床或生化检查疑似前列腺癌的患者,68Ga-PSMA PET/CT的高敏感度和低阴性似然比提示其可能用于排除诊断。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. Early diagnosis is important in the overall management of prostate cancer (PCa). Gallium-68-labeled prostate-specific membrane antigen (PSMA) PET/CT has an established role in the detection of recurrent disease and staging of patients with intermediate- to high-risk PCa. However, only a small number of studies have evaluated its role in the initial diagnosis of PCa. OBJECTIVE. This systematic review was conducted to evaluate the diagnostic performance of 68Ga-PSMA PET/CT in the initial detection of PCa in patients with clinical or biochemical findings suspicious for PCa. EVIDENCE ACQUISITION. This systematic review followed PRISMA guidelines. Searches in PubMed, Scopus, and Embase were conducted using relevant keywords, and articles published through April 30, 2020, were included. Using histopathology results as the reference standard, the numbers of true- and false-positives and true- and false-negatives were extracted. Pooled estimates of diagnostic test accuracy-including sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and summary ROC (SROC) curve-were generated using bivariate random-effects meta-analysis. EVIDENCE SYNTHESIS. Seven studies comprising 389 patients were included in the systematic review and meta-analysis. The pooled sensitivity, specificity, positive likelihood ratio, and negative likelihood ratio for the initial diagnosis of PCa using 68Ga-PSMA PET/CT were 0.97 (95% CI, 0.90-0.99), 0.66 (95% CI, 0.52-0.78), 2.86 (95% CI, 1.95-4.20), and 0.05 (95% CI, 0.01-0.15), respectively. The test had high accuracy; the area under the SROC curve was 0.91 (95% CI, 0.88-0.93). CONCLUSION. Gallium-68-labeled PSMA PET/CT had excellent sensitivity and negative likelihood ratio in the initial diagnosis of PCa in patients with clinical or biochemical findings suspicious for PCa. CLINICAL IMPACT. Gallium-68-labeled PSMA PET/CT had high diagnostic accuracy for the initial detection of PCa in patients with clinical or biochemical findings suspicious for PCa and has potential utility as a rule-out test for these patients.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Satapathy S, Singh H, Kumar R, et al. Diagnostic Accuracy of 68Ga-PSMA PET/CT for Initial Detection in Patients With Suspected Prostate Cancer: A Systematic Review and Meta-Analysis. AJR Am J Roentgenol. 2021. PMID: 32755196. doi:10.2214/AJR.20.23912

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。